Altogether, our data provide evidence that YM155 is an effective cell death inducer in breast cancer cells, even in presence of their microenvironment and that both homeostatic pathways NF-kB and autophagy control the signaling pathway leading to cell death in YM155-treated cells. Here, NFKB1 is linked to breast carcinoma.